search
Back to results

Effects of Cycling Dual-task in Parkinson's Disease.

Primary Purpose

Parkinson Disease

Status
Recruiting
Phase
Not Applicable
Locations
Spain
Study Type
Interventional
Intervention
Cycling exercise
Cognitive tasks
Sponsored by
University of Vigo
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Parkinson Disease

Eligibility Criteria

undefined - undefined (Child, Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Parkinson disease
  • Hoehn and Yahr 1 and 2

Exclusion Criteria:

  • Hoehn and Yahr >2

Sites / Locations

  • University of VigoRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Cycling combined with cognitive tasks

Cycling

Arm Description

Outcomes

Primary Outcome Measures

Timed Up and Go
Dynamic balance
Sit to Stand test
Lower limbs strength
Movement Disorder Society - Unified Parkinson's Disease Rating Scale
Parkinson's Disease rating
Parkinson's Disease Questionnaire - 39
Quality of life

Secondary Outcome Measures

Trail Making Test A & B
Attention, visual screening ability and processing speed
Stroop test
Ability to inhibit cognitive interference

Full Information

First Posted
September 29, 2022
Last Updated
May 24, 2023
Sponsor
University of Vigo
search

1. Study Identification

Unique Protocol Identification Number
NCT05565300
Brief Title
Effects of Cycling Dual-task in Parkinson's Disease.
Official Title
Effects of a Forced Cycling Program With Cognitive Stimulation on Symptomatology, Physical Condition, and Cognition in People Diagnosed With Parkinson's Disease.
Study Type
Interventional

2. Study Status

Record Verification Date
May 2023
Overall Recruitment Status
Recruiting
Study Start Date
September 15, 2022 (Actual)
Primary Completion Date
December 2023 (Anticipated)
Study Completion Date
December 2023 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Vigo

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Taking into account the process of functional and cognitive evolution that patients with Parkinson's disease experience throughout the evolution of the pathology, the objective of this study is to evaluate the effect of a dual-task program combining cognitive tasks and forced cycling on the functional and cognitive capacity of these patients.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Parkinson Disease

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantOutcomes Assessor
Allocation
Randomized
Enrollment
44 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Cycling combined with cognitive tasks
Arm Type
Experimental
Arm Title
Cycling
Arm Type
Active Comparator
Intervention Type
Other
Intervention Name(s)
Cycling exercise
Intervention Description
30 minutes of cycling (90 rpm).
Intervention Type
Other
Intervention Name(s)
Cognitive tasks
Intervention Description
30 minutes of cognitive tasks based on the different domains of the Mini Mental Scale.
Primary Outcome Measure Information:
Title
Timed Up and Go
Description
Dynamic balance
Time Frame
Change from Baseline Timed Up and Go at 12 weeks
Title
Sit to Stand test
Description
Lower limbs strength
Time Frame
Change from Baseline Sit to Stand Test at 12 weeks
Title
Movement Disorder Society - Unified Parkinson's Disease Rating Scale
Description
Parkinson's Disease rating
Time Frame
Change from Baseline Unified Parkinson's Disease Rating Scale at 12 weeks (0-159, better lower values)
Title
Parkinson's Disease Questionnaire - 39
Description
Quality of life
Time Frame
Change from Baseline Parkinson's Disease Questionnaire - 39 at 12 weeks (0-100, better lower values)
Secondary Outcome Measure Information:
Title
Trail Making Test A & B
Description
Attention, visual screening ability and processing speed
Time Frame
Change from Baseline Trail Making Test A & B at 12 weeks
Title
Stroop test
Description
Ability to inhibit cognitive interference
Time Frame
Change from Baseline Stroop Test at 12 weeks

10. Eligibility

Sex
All
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Parkinson disease Hoehn and Yahr 1 and 2 Exclusion Criteria: Hoehn and Yahr >2
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Iris M de Oliveira
Phone
034 986801768
Email
irismacoli@uvigo.es
Facility Information:
Facility Name
University of Vigo
City
Pontevedra
ZIP/Postal Code
36005
Country
Spain
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Iris M de Oliveira, Ph.D.
Phone
034 986801768
Email
irismacoli@uvigo.es
First Name & Middle Initial & Last Name & Degree
Karina P Pereira-Pedro, M.Sc
First Name & Middle Initial & Last Name & Degree
Irimia Mollinedo Cardalda, Ph.D.
First Name & Middle Initial & Last Name & Degree
Esther Monge-Pereira, Ph.D.
First Name & Middle Initial & Last Name & Degree
José María Cancela Carral, Ph.D
First Name & Middle Initial & Last Name & Degree
Iris M de Oliveira, Ph.D

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Effects of Cycling Dual-task in Parkinson's Disease.

We'll reach out to this number within 24 hrs